Annual Current Liabilities
$24.79 M
-$15.20 M-38.00%
01 July 2024
Summary:
Enzo Biochem annual total current liabilities is currently $24.79 million, with the most recent change of -$15.20 million (-38.00%) on 01 July 2024. During the last 3 years, it has fallen by -$1.28 million (-4.92%). ENZ annual current liabilities is now -42.87% below its all-time high of $43.40 million, reached on 31 July 1991.ENZ Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$24.79 M
+$3.13 M+14.45%
01 July 2024
Summary:
Enzo Biochem quarterly total current liabilities is currently $24.79 million, with the most recent change of +$3.13 million (+14.45%) on 01 July 2024. Over the past year, it has dropped by -$4.05 million (-14.04%). ENZ quarterly current liabilities is now -42.87% below its all-time high of $43.40 million, reached on 31 July 1991.ENZ Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | -14.0% |
| 3 y3 years | -4.9% | +7.3% |
| 5 y5 years | +54.9% | +7.8% |
ENZ Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.0% | +90.4% | -41.2% | +90.4% |
| 5 y | 5 years | -38.0% | +90.4% | -41.2% | +90.4% |
| alltime | all time | -42.9% | +2999.3% | -42.9% | +2999.3% |
Enzo Biochem Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $24.79 M(-38.0%) | $24.79 M(+14.5%) |
| Apr 2024 | - | $21.66 M(-14.3%) |
| Jan 2024 | - | $25.28 M(-12.3%) |
| Oct 2023 | - | $28.84 M(-27.9%) |
| July 2023 | $39.99 M(+207.2%) | $39.99 M(-5.1%) |
| Apr 2023 | - | $42.15 M(+30.9%) |
| Jan 2023 | - | $32.20 M(+32.8%) |
| Oct 2022 | - | $24.25 M(+86.3%) |
| July 2022 | $13.02 M(-50.1%) | $13.02 M(-47.3%) |
| Apr 2022 | - | $24.70 M(-5.5%) |
| Jan 2022 | - | $26.15 M(+13.2%) |
| Oct 2021 | - | $23.11 M(-11.4%) |
| July 2021 | $26.08 M(-20.5%) | $26.08 M(-10.7%) |
| Apr 2021 | - | $29.21 M(-2.5%) |
| Jan 2021 | - | $29.95 M(-10.9%) |
| Oct 2020 | - | $33.61 M(+2.5%) |
| July 2020 | $32.80 M(+104.9%) | $32.80 M(+2.9%) |
| Apr 2020 | - | $31.87 M(+37.4%) |
| Jan 2020 | - | $23.20 M(+0.9%) |
| Oct 2019 | - | $23.00 M(+43.7%) |
| July 2019 | $16.01 M(-20.7%) | $16.01 M(+4.8%) |
| Apr 2019 | - | $15.27 M(-8.0%) |
| Jan 2019 | - | $16.60 M(-8.8%) |
| Oct 2018 | - | $18.19 M(-9.9%) |
| July 2018 | $20.19 M(+13.3%) | $20.19 M(+8.1%) |
| Apr 2018 | - | $18.67 M(-6.1%) |
| Jan 2018 | - | $19.87 M(+1.7%) |
| Oct 2017 | - | $19.54 M(+9.7%) |
| July 2017 | $17.81 M(-13.4%) | $17.81 M(+5.0%) |
| Apr 2017 | - | $16.96 M(-3.5%) |
| Jan 2017 | - | $17.57 M(-15.5%) |
| Oct 2016 | - | $20.78 M(+1.0%) |
| July 2016 | $20.57 M(-14.1%) | $20.57 M(-5.1%) |
| Apr 2016 | - | $21.67 M(-11.6%) |
| Jan 2016 | - | $24.50 M(-5.0%) |
| Oct 2015 | - | $25.79 M(+7.6%) |
| July 2015 | $23.96 M(-4.0%) | $23.96 M(+6.3%) |
| Apr 2015 | - | $22.54 M(-0.7%) |
| Jan 2015 | - | $22.69 M(-7.4%) |
| Oct 2014 | - | $24.51 M(-1.8%) |
| July 2014 | $24.96 M(+4.7%) | $24.96 M(+12.7%) |
| Apr 2014 | - | $22.14 M(-2.2%) |
| Jan 2014 | - | $22.65 M(-6.6%) |
| Oct 2013 | - | $24.24 M(+1.6%) |
| July 2013 | $23.85 M(+25.8%) | $23.85 M(+15.0%) |
| Apr 2013 | - | $20.73 M(+1.4%) |
| Jan 2013 | - | $20.44 M(+3.1%) |
| Oct 2012 | - | $19.84 M(+4.6%) |
| July 2012 | $18.96 M(+6.9%) | $18.96 M(+16.1%) |
| Apr 2012 | - | $16.32 M(-4.5%) |
| Jan 2012 | - | $17.10 M(-2.7%) |
| Oct 2011 | - | $17.56 M(-0.9%) |
| July 2011 | $17.73 M(+14.0%) | $17.73 M(+11.7%) |
| Apr 2011 | - | $15.87 M(-6.1%) |
| Jan 2011 | - | $16.89 M(+6.8%) |
| Oct 2010 | - | $15.82 M(+1.7%) |
| July 2010 | $15.56 M(+11.6%) | $15.56 M(+26.5%) |
| Apr 2010 | - | $12.30 M(-36.6%) |
| Jan 2010 | - | $19.41 M(+46.5%) |
| Oct 2009 | - | $13.25 M(-5.0%) |
| July 2009 | $13.94 M(+4.9%) | $13.94 M(-12.1%) |
| Apr 2009 | - | $15.86 M(+10.9%) |
| Jan 2009 | - | $14.30 M(+10.7%) |
| Oct 2008 | - | $12.92 M(-2.8%) |
| July 2008 | $13.29 M(-8.0%) | $13.29 M(+17.6%) |
| Apr 2008 | - | $11.30 M(+7.1%) |
| Jan 2008 | - | $10.55 M(-19.9%) |
| Oct 2007 | - | $13.17 M(-8.8%) |
| July 2007 | $14.44 M(+143.2%) | $14.44 M(+63.1%) |
| Apr 2007 | - | $8.85 M(+12.6%) |
| Jan 2007 | - | $7.86 M(-0.7%) |
| Oct 2006 | - | $7.92 M(+33.3%) |
| July 2006 | $5.94 M | $5.94 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2006 | - | $6.97 M(+34.8%) |
| Jan 2006 | - | $5.17 M(-14.2%) |
| Oct 2005 | - | $6.03 M(-22.6%) |
| July 2005 | $7.79 M(+43.6%) | $7.79 M(+43.5%) |
| Apr 2005 | - | $5.43 M(-17.8%) |
| Jan 2005 | - | $6.60 M(-39.8%) |
| Oct 2004 | - | $10.96 M(+102.0%) |
| July 2004 | $5.42 M(+4.8%) | $5.42 M(+30.0%) |
| Apr 2004 | - | $4.17 M(+0.8%) |
| Jan 2004 | - | $4.14 M(-18.8%) |
| Oct 2003 | - | $5.09 M(-1.6%) |
| July 2003 | $5.18 M(+80.8%) | $5.18 M(+29.7%) |
| Apr 2003 | - | $3.99 M(+3.7%) |
| Jan 2003 | - | $3.85 M(+15.4%) |
| Oct 2002 | - | $3.33 M(+16.5%) |
| July 2002 | $2.86 M(-14.5%) | $2.86 M(-35.4%) |
| Apr 2002 | - | $4.43 M(+6.6%) |
| Jan 2002 | - | $4.16 M(+43.4%) |
| Oct 2001 | - | $2.90 M(-13.3%) |
| July 2001 | $3.35 M(-7.6%) | $3.35 M(+22.9%) |
| Apr 2001 | - | $2.72 M(-5.1%) |
| Jan 2001 | - | $2.87 M(-1.6%) |
| Oct 2000 | - | $2.92 M(-19.5%) |
| July 2000 | $3.62 M(+51.0%) | $3.62 M(+73.4%) |
| Apr 2000 | - | $2.09 M(-5.0%) |
| Jan 2000 | - | $2.20 M(-15.4%) |
| Oct 1999 | - | $2.60 M(+8.3%) |
| July 1999 | $2.40 M(0.0%) | $2.40 M(+33.3%) |
| Apr 1999 | - | $1.80 M(-10.0%) |
| Jan 1999 | - | $2.00 M(-9.1%) |
| Oct 1998 | - | $2.20 M(-8.3%) |
| July 1998 | $2.40 M(0.0%) | $2.40 M(+14.3%) |
| Apr 1998 | - | $2.10 M(-8.7%) |
| Jan 1998 | - | $2.30 M(+43.8%) |
| Oct 1997 | - | $1.60 M(-33.3%) |
| July 1997 | $2.40 M(-63.1%) | $2.40 M(+33.3%) |
| Apr 1997 | - | $1.80 M(+20.0%) |
| Jan 1997 | - | $1.50 M(-44.4%) |
| Oct 1996 | - | $2.70 M(-58.5%) |
| July 1996 | $6.50 M(+12.1%) | $6.50 M(+32.7%) |
| Apr 1996 | - | $4.90 M(+2.1%) |
| Jan 1996 | - | $4.80 M(+4.3%) |
| Oct 1995 | - | $4.60 M(-20.7%) |
| July 1995 | $5.80 M(-32.6%) | $5.80 M(-13.4%) |
| Apr 1995 | - | $6.70 M(-2.9%) |
| Jan 1995 | - | $6.90 M(-29.6%) |
| Oct 1994 | - | $9.80 M(+14.0%) |
| July 1994 | $8.60 M(-16.5%) | $8.60 M(+59.3%) |
| Apr 1994 | - | $5.40 M(+68.8%) |
| Jan 1994 | - | $3.20 M(-46.7%) |
| Oct 1993 | - | $6.00 M(-41.7%) |
| July 1993 | $10.30 M(-14.9%) | $10.30 M(-8.8%) |
| Apr 1993 | - | $11.30 M(-2.6%) |
| Jan 1993 | - | $11.60 M(-1.7%) |
| Oct 1992 | - | $11.80 M(-2.5%) |
| July 1992 | $12.10 M(-72.1%) | $12.10 M(+37.5%) |
| Apr 1992 | - | $8.80 M(+4.8%) |
| Jan 1992 | - | $8.40 M(-80.5%) |
| Oct 1991 | - | $43.00 M(-0.9%) |
| July 1991 | $43.40 M(+675.0%) | $43.40 M(+4.3%) |
| Apr 1991 | - | $41.60 M(+197.1%) |
| Jan 1991 | - | $14.00 M(+185.7%) |
| Oct 1990 | - | $4.90 M(-12.5%) |
| July 1990 | $5.60 M(+1.8%) | $5.60 M(+21.7%) |
| Apr 1990 | - | $4.60 M(-19.3%) |
| Jan 1990 | - | $5.70 M(+21.3%) |
| Oct 1989 | - | $4.70 M(-14.5%) |
| July 1989 | $5.50 M(+150.0%) | $5.50 M(+150.0%) |
| July 1988 | $2.20 M(-18.5%) | $2.20 M(-18.5%) |
| July 1987 | $2.70 M(+35.0%) | $2.70 M(+35.0%) |
| July 1986 | $2.00 M(+150.0%) | $2.00 M(+150.0%) |
| July 1985 | $800.00 K(-33.3%) | $800.00 K(-33.3%) |
| July 1984 | $1.20 M | $1.20 M |
FAQ
- What is Enzo Biochem annual total current liabilities?
- What is the all time high annual current liabilities for Enzo Biochem?
- What is Enzo Biochem annual current liabilities year-on-year change?
- What is Enzo Biochem quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enzo Biochem?
- What is Enzo Biochem quarterly current liabilities year-on-year change?
What is Enzo Biochem annual total current liabilities?
The current annual current liabilities of ENZ is $24.79 M
What is the all time high annual current liabilities for Enzo Biochem?
Enzo Biochem all-time high annual total current liabilities is $43.40 M
What is Enzo Biochem annual current liabilities year-on-year change?
Over the past year, ENZ annual total current liabilities has changed by -$15.20 M (-38.00%)
What is Enzo Biochem quarterly total current liabilities?
The current quarterly current liabilities of ENZ is $24.79 M
What is the all time high quarterly current liabilities for Enzo Biochem?
Enzo Biochem all-time high quarterly total current liabilities is $43.40 M
What is Enzo Biochem quarterly current liabilities year-on-year change?
Over the past year, ENZ quarterly total current liabilities has changed by -$4.05 M (-14.04%)